Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis
Zakariya Kashour, Muhammad Riaz, Musa A. Garbati, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 76, Iss. 1, pp. 30-42
Open Access | Times Cited: 125

Showing 1-25 of 125 citing articles:

Antimicrobial resistance and COVID-19: Intersections and implications
Gwenan M. Knight, R. E. Glover, Christopher Finn McQuaid, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 281
Mortality in patients admitted to intensive care with COVID‐19: an updated systematic review and meta‐analysis of observational studies
R. A. Armstrong, Andrew D. Kane, E. Kursumovic, et al.
Anaesthesia (2021) Vol. 76, Iss. 4, pp. 537-548
Open Access | Times Cited: 145
Drug repositioning: Progress and challenges in drug discovery for various diseases
Yi Hua, Xiaowen Dai, Yuan Xu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114239-114239
Open Access | Times Cited: 112
A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment
Ramy Mohamed Ghazy, Abdallah Almaghraby, Ramy Shaaban, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 107
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
Amin Gasmi, Massimiliano Peana, Sàdaf Noor, et al.
Applied Microbiology and Biotechnology (2021) Vol. 105, Iss. 4, pp. 1333-1343
Open Access | Times Cited: 84
Network bioinformatics analysis provides insight into drug repurposing for COVID-19
Li Xu, Jinchao Yu, Zhiming Zhang, et al.
Medicine in Drug Discovery (2021) Vol. 10, pp. 100090-100090
Open Access | Times Cited: 78
Effectiveness of favipiravir in COVID-19: a live systematic review
Batu Özlüşen, Şima Kozan, Rüştü Emre Akcan, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2021) Vol. 40, Iss. 12, pp. 2575-2583
Open Access | Times Cited: 68
Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy
Mona Sadat Mirtaleb, Amir Hossein Mirtaleb, Hassan Nosrati, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111518-111518
Open Access | Times Cited: 60
Characteristics, quality and volume of the first 5 months of the COVID-19 evidence synthesis infodemic: a meta-research study
Rebecca Abbott, Alison Bethel, Morwenna Rogers, et al.
BMJ evidence-based medicine (2021) Vol. 27, Iss. 3, pp. 169-177
Open Access | Times Cited: 45
Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
Safaet Alam, Taslima Binte Kamal, Md. Moklesur Rahman Sarker, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 42
Consumption Trends of Antibiotics in Brazil During the COVID-19 Pandemic
Fernando de Sá Del Fiol, Cristiane de Cássia Bergamaschi, Isaltino Pereira De Andrade, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Pseudoscience and fraudulent products for COVID-19 management
Vivek P. Chavda, Shreya S. Sonak, Nafesa K. Munshi, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 42, pp. 62887-62912
Open Access | Times Cited: 27
Exploring diverse frontiers: Advancements of bioactive 4-aminoquinoline-based molecular hybrids in targeted therapeutics and beyond
Lekkala Ravindar, Siti Aishah Hasbullah, K.P. Rakesh, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116043-116043
Closed Access | Times Cited: 19
The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: A Review
Felix Scholkmann, Tanja Restin, Marco Ferrari, et al.
Journal of Clinical Medicine (2020) Vol. 10, Iss. 1, pp. 50-50
Open Access | Times Cited: 40
Misinformation on social networks during the novel coronavirus pandemic: a quali-quantitative case study of Brazil
Priscila Biancovilli, Lilla Makszin, Cláudia Jurberg
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 39
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi, et al.
Infectious Diseases and Therapy (2021) Vol. 10, Iss. 4, pp. 1837-1885
Open Access | Times Cited: 33
Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors
Jiahua Cui, Jinping Jia
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113789-113789
Open Access | Times Cited: 33
Efficacy and safety of ivermectin for the treatment of COVID-19: a systematic review and meta-analysis
Jiawen Deng, Fangwen Zhou, Saif Ali, et al.
QJM (2021) Vol. 114, Iss. 10, pp. 721-732
Open Access | Times Cited: 33
The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis
Jean Bousquet, Mondher Toumi, Bernardo Sousa‐Pinto, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 11, pp. 2878-2888
Open Access | Times Cited: 24
Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus Infections
Qiongqiong Angela Zhou, Junko Kato-Weinstein, Yingzhu Li, et al.
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 5, pp. 813-834
Open Access | Times Cited: 36
Heterocyclic compounds as antiviral drugs: Synthesis, structure–activity relationship and traditional applications
Giovanny Carvalho dos Santos, Lucas Michelão Martins, Bruna Andressa Bregadiolli, et al.
Journal of Heterocyclic Chemistry (2021) Vol. 58, Iss. 12, pp. 2226-2260
Closed Access | Times Cited: 31
Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of Plasmodium falciparum Infection Be Protective?
Allan Kalungi, Eugene Kinyanda, Dickens Akena, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 28
Understanding the Molecular Biology of SARS-CoV-2 and the COVID-19 Pandemic: A Review
Sarah Alsobaie
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 2259-2268
Open Access | Times Cited: 27
Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
Rania M. Sarhan, Hadeer S. Harb, Ahmed E. Abou Warda, et al.
Journal of Infection and Public Health (2021) Vol. 15, Iss. 1, pp. 116-122
Open Access | Times Cited: 27
Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
Pawan Kumar Raghav, Zoya Mann, Simran Kaur Ahluwalia, et al.
Journal of Pharmacological Sciences (2023) Vol. 152, Iss. 1, pp. 1-21
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top